This article has Open Peer Review reports available.
Successful treatment of methemoglobinemia in an elderly couple with severe cyanosis: two case reports
© Su et al.; licensee BioMed Central Ltd. 2012
Received: 6 October 2011
Accepted: 1 March 2012
Published: 11 September 2012
Methemoglobinemia should be considered in all cyanotic patients who remain unresponsive to oxygen therapy. Rapid diagnosis is very important in emergency cases. Here, we present the cases of two patients, a married couple, admitted to our hospital with methemoglobinemia after exposure to sodium nitrite.
Two patients, a married couple, presented with methemoglobinemia. The 72-year-old Taiwanese man and 68-year-old Taiwanese woman were referred to our hospital with dizziness and tachypnea. On examination, their mucous membranes were cyanotic, and their blood samples showed the classic ‘chocolate brown’ appearance. The man also reported having experienced twitching of his right arm for a few minutes before arrival at the hospital. The symptoms of both patients failed to improve in response to supplemental oxygen delivered via oxygen masks, although the arterial blood gas data of these patients were normal and their pulse oximetry showed oxyhemoglobin levels of approximately 85%. A carbon monoxide-oximeter showed that the man’s methemoglobin concentration was 48.3%, and the woman’s was 36.4%. Methylene blue (100mg) was administered intravenously to both patients, and their symptoms improved dramatically. They were admitted to the intensive care unit and discharged three days later, without neurological sequelae.
Severe methemoglobinemia is a life-threatening condition and, if untreated, may result in death. Early diagnosis and appropriate antidotal treatment are crucial in treating this emergency situation.
Hemoglobins can be classified into two groups: those capable of binding oxygen (O2; normal hemoglobins) and those incapable of binding O2 (dyshemoglobins). Methemoglobin represents the oxidized form (Fe3+-Hb) of hemoglobin, which is incapable of carrying oxygen . Acquired methemoglobinemia can result from exposure to a wide range of drugs and chemicals, including nitrites and other oxidants. Signs and symptoms of methemoglobinemia, which may correlate with measured methemoglobin level, include headache, tachypnea, cyanosis, and changes in mental status. Arterial blood gas and pulse oximeter measurements offer limited diagnostic help and may be misleading. We present the case of two patients who, to avoid a lethal outcome, were diagnosed within an hour as having acquired methemoglobinemia. Before the admission, our patients had ingested food containing large amounts of sodium nitrite, as determined using a specific test paper (see below). Further evidence to support the diagnosis was obtained through physical examination and successful treatment with methylene blue. This case provides a successful model for emergency treatment for methemoglobinemia.
Our second patient was a 68-year-old Taiwanese woman who attended our hospital with the same complaints as her husband, as described above. Like her husband, she had no relevant past medical history. On inspection, she had mild generalized cyanosis, pale grey lips, and bluish nail beds. Her vital signs at presentation were as follows: pulse rate, 90 beats/min; respiratory rate, 27breaths/min; and blood pressure, 96/66mmHg. Her chest was clear on auscultation. Her blood samples were also of the classic chocolate-brown color indicative of methemoglobinemia. On 8L/min of supplemental oxygen, pulse oximetry showed an oxygen saturation of 88%, and arterial blood gas analysis showed a partial pressure of O2 of 172.9mmHg (80 to 105mmHg) and a hemoglobin O2 saturation level of 96.3%. As was the case in our male patient, electrocardiography showed diffuse ST depression, although her cardiac enzyme levels were within the normal range.
Methemoglobinemia is a rare cause of cyanosis which should be promptly recognized and well treated. Some cases of acquired methemoglobinemia may result from exposure to certain drugs during medical testing. The symptoms of methemoglobinemia can range in severity from dizziness to coma. Patients may present with cyanosis when the methemoglobin concentration reaches levels of approximately 10% of the total hemoglobin level . In normal circumstances, the enzyme nicotinamide adenine dinucleotide-methemoglobin reductase reduces methemoglobin to hemoglobin, preventing the accumulation of methemoglobin. If this usual mechanism is overwhelmed by exogenous oxidative stress, acquired methemoglobinemia ensues. A second enzymatic pathway uses nicotinamide adenosine dinucleotide phosphate and nicotinamide adenosine dinucleotide phosphate-methemoglobin reductase, which is important for the antidotal effect of methylene blue when administered exogenously . Patients with methemoglobinemia tend to present with a more serious condition than anemic patients, who show a similar reduction in oxygen-carrying capacity due to a leftward shift in the oxyhemoglobin dissociation curve . Profound cyanosis incompatible with the degree of respiratory distress, especially where cyanotic symptoms are unresponsive to oxygen therapy, should raise the suspicion of methemoglobinemia. This diagnosis is supported by the chocolate-brown coloration of blood samples obtained from these patients, and the diagnosis may be confirmed by the results of CO-oximeter.
Nitrites and aniline derivatives have been reported to be among the chemical agents that most commonly cause methemoglobinemia . A review of the literature showed that the reported lethal dose of sodium nitrite in adults is approximately 2.6g . Our two patients showed recovery from the effects of the consumption of almost 3g of sodium nitrite from the soup. The onset of methemoglobinemia occurs usually within 20 to 60 minutes of chemical exposure, although the clinical evolution is difficult to predict concerning these toxic agents. Generally, 10% to 15% methemoglobin saturation produces obvious cyanosis . Methemoglobin concentrations of 50% to 60% impair oxygen delivery, resulting in myocardial ischemia, depressed mental status and seizures, as observed in the case of our patients.
In our patients, the difference between oxygen saturation measured by the pulse oximeter and blood gas analysis led us to consider the possibility of dyshemoglobinemia. The oxygen saturation measured by pulse oximetry typically presents values of around 85% in patients with methemoglobinemia . When patients have significantly elevated methemoglobin levels (>20%), the pulse oximeter falsely indicates high levels of oxygen saturation. Arterial blood gas analysis may also be initially deceptive, because the partial pressure of O2, as a measure of dissolved oxygen, is normal. Thus, extrapolation of this figure to predict the expected oxygen saturation will provide a falsely elevated result. The best definitive diagnostic test is multiple wavelength CO-oximetry, an in vitro spectrophotometric method that is capable of differentiating between oxy-, deoxy-, met- and carboxyhemoglobin .
In the case of patients diagnosed with methemoglobinemia, the optimum treatment is adequate oxygen delivery and appropriate antidotal therapy. Methylene blue is indicated as the first-line antidotal therapy for patients with severe methemoglobinemia. Although successful treatment with plasma exchange therapy, hyperbaric oxygen therapy and ascorbic acid has also been reported, these therapies should be considered as second-line treatments for patients unresponsive to methylene blue. As the methemoglobin level falls, the most severe signs and symptoms will be the first to resolve. As observed in our patients, symptoms of dyspnea and depressed mental status subsided within 30 minutes of methylene blue injection. Cyanosis usually resolves somewhat later, after the levels of methemoglobin have fallen to below 1.5g/dL. The initial dose of methylene blue is 1 to 2mg/kg intravenously. If symptoms of hypoxia fail to subside, the same dose may be repeated within 1 hour .
Methemoglobinemia should be considered in all patients with cyanosis who are unresponsive to oxygen therapy. Rapid diagnosis and early intervention with antidotal therapy should prevent a fatal outcome. Moreover, the simple Roche Combur 10 Test® M test strips can provide rapid and accurate evidence of the possible presence of nitrites in human body fluids. The treatment of choice is intravenous methylene blue infusion, which should be available in all emergency departments.
Written informed consent was obtained from the patients for publication of this manuscript and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We would like to thank Dr Deng JF and Dr Wu ML in the Department of Clinical Toxicology at the National Poison Control Center for kindly assisting in the detection of nitrites in the bamboo shoot soup and patients' blood. We also would like to thank Miss Cheng-Fan Wen for her assistance.
- Ash-Bernal R, Wise R, Wright SM: Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). 2004, 83: 265-273. 10.1097/01.md.0000141096.00377.3f.View ArticleGoogle Scholar
- Guevara I, Iwanejko J, Dembińska-Kieć A, Pankiewicz J, Wanat A, Anna P, Gołabek I, Bartuś S, Malczewska-Malec M, Szczudlik A: Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta. 1998, 274: 177-188. 10.1016/S0009-8981(98)00060-6.View ArticlePubMedGoogle Scholar
- Henretig FM, Gribetz B, Kearney T, Lacouture P, Lovejoy FH: Interpretation of color change in blood with varying degree of methemoglobinemia. J Toxicol Clin Toxicol. 1988, 26: 293-301.View ArticlePubMedGoogle Scholar
- Rehman HU: Methemoglobinemia. West J Med. 2001, 175: 193-196. 10.1136/ewjm.175.3.193.View ArticlePubMedPubMed CentralGoogle Scholar
- Respiratory disorders. Edited by: Wilson SF, Tompson JM. 1990, Mosby-Year Book, St. Louis, 15Google Scholar
- Donovan JW: Nitrates, nitrites and other sources of methemoglobinemia. Clinical management of poisoning and drug overdose. Edited by: Haddad LM, Winchester JF. 1990, W.B. Saunders Company, Philadelphia, 1419-1431.Google Scholar
- Wright RO, Lewander WJ, Woolf AD: Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999, 34: 646-656. 10.1016/S0196-0644(99)70167-8.View ArticlePubMedGoogle Scholar
- Coleman MD, Coleman NA: Drug induced methemoglobinemia. Treatment issues. Drug Saf. 1996, 14: 394-405. 10.2165/00002018-199614060-00005.View ArticlePubMedGoogle Scholar
- Haymond S, Cariappa R, Eby CS, Scott MG: Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005, 51: 434-444. 10.1373/clinchem.2004.035154.View ArticlePubMedGoogle Scholar
- Rees SM, Nelson LS: Dyshemoglobinemias. Emergency medicine - a comprehensive study guide. Edited by: Tintinalli JE, Kelen GD, Stapczynski JS. 2004, McGraw-Hill, New York, 1169-1171. 6Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.